Summary
Multiple splicing sites exist in the RNA genome of the human immunodeficiency virus type 1 (HIV-1). In a screen for subgenomic forms of the HIV-1 genome that could be transferred to fresh cells by virus infection, we identified a novel spliced variant of HIV-1 RNA that uses a hitherto unknown splice acceptor site within the envelope (Env) gene. We demonstrate that this splice acceptor is infrequently used in HIV-infected T cells. Interestingly, an AUG initiator codon is created at this splice junction which has the potential to direct the synthesis of the cytoplasmic tail of the Env gp41 protein. Transient transfection experiments with the new cDNA cloned in an expression vector demonstrated efficient utilization of this start codon and the C-terminus of the Env open reading frame. Independent expression of the 152 amino acid long, intracellular Env domain provides novel regulatory mechanisms for modulating viral infectivity and perhaps pathogenicity.
Similar content being viewed by others
References
Cullen BR (1992) Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol Rev 56: 75–394
Garcia JA, Gaynor RB (1994) Regulatory mechanisms involved in the control of HIV-1 gene expression. AIDS 8: S3-S17
Arrigo SJ, Weitsman S, Zack JA, Chen ISY (1990) Characterization and expression of novel singly spliced RNA species of human immunodeficiency virus type 1. J Virol 64: 4585–4588
Guatelli JC, Gingeras TR, Richman DD (1990) Alternative splice acceptor utilization during human immunodeficiency virus type 1 infection of cultured cells. J Virol 64: 40933–4098
Robert-Guroff M, Popovic M, Gartner S, Markham P, Gallo RC, Reitz MS (1990) Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages. J Virol 64: 3391–3398
Schwartz S, Felber BK, Benko DM, Fenyo EM, Pavlakis GN (1990) Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J Virol 64: 2519–2529
Schwartz S, Felber BK, Fenyo EM, Pavlakis GN (1990) Env and VpU proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs. J Virol 64: 5448–5456
Purcell DFJ, Martin MA (1993) Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol 67: 6365–6378
Benko DM, Schwartz S, Pavlakis GN, Felber BK (1990) A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins. J Virol 64: 2505–2518
Furtado MR, Balachandran R, Gupta P, Wolinsky SM (1991) Analysis of alternatively spliced human immunodeficiency virus type-1 mRNA species, one of which encodes a novel Tat-Env fusion protein. Virology 185: 258–270
Göttlinger HG, Dorfman T, Cohen EA, Haseltine WA (1992) The role of tnv protein and tnv RNA splicing signals in replication of HIV-1 IIIB isolates. Virology 189: 618–628
Salfeld J, Göttlinger H, Sia R, Park R, Sodroski J, Haseltine W (1990) A tripartite HIV-1 tat-env-rev fusion protein. EMBO J 9: 965–970
Schwartz S, Felber BK, Benko DM, Fenyo EM, Pavlakis GN (1990) Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J Virol 64: 2519–2529
Das AT, Klaver B, Berkhout B (1995) Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNAlys,3. J Virol 69: 3090–3097
Peden K, Emerman M, Montagnier L (1991) Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1 LAI, HIV-1 MAL and HIV-1 ELI. Virology 185: 661–672
Chirgwin JM, Przybyla AE, McDonald RJ, Rutter WJ (1979) Isolation and biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294–5299
Berkhout B, Silverman R, Jeang K-T (1989) Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell 59: 273–282
de Ronde A, Klaver B, Keulen W, Smit L, Goudsmit J (1992) Natural nef accelerates virus replication in primary human lymphocytes. Virology 188: 391–395
Coffin JM (1986) Genetic variation in AIDS viruses. Cell 46: 1–4
Barrett ADT, Dimmock NJ (1986) Defective interfering viruses and infections of animals. Curr Top Microbiol Immunol 128: 55–84
Voynow SL, Coffin JM (1985) Evolutionary variants of Rous sarcoma virus: large deletion mutants do not result from homologous recombination. J Virol 55: 67–78
Muesing MA, Smith DH, Cabradilla CD, Benton CV, Lasky LA, Capon DJ (1985) Nucleic acid structure and expression of the human AIDS/lymphadenopathy virus. Nature 313: 450–458
Kozak M (1989) The scanning model for translation: an update. J Cell Biol 108: 229–241
Schwartz S, Felber BK, Pavlakis GN (1992) Mechanism of translation of monocistronic and multicistronic human immunodeficiency virus type 1 mRNAs. Mol Cell Biol 12: 207–219
Kozak M (1986) Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44: 283–292
Aldovini A, Young RA (1990) Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J Virol 64: 1920–1926
Clavel F, Orenstein JM (1990) A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology. J Virol 64: 5230–5234
Aronoff R, Linial M (1991) Specificity of retroviral RNA packaging. J Virol 65: 71–80
Richardson JH, Child LA, Lever AML (1993) Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5′ leader region. J Virol 67: 3997–4005
Richardson JH, Kaye JF, Child LA, Lever AML (1995) Helper virus-free transfer of human immunodeficiency virus type 1 vectors. J Gen Virol 76: 691–696
Saïb A, Périès J, de Thé H (1993) A defective human foamy provirus generated by pregenome splicing. EMBO J 12: 4439–4444
Myers G, Wain-Hobson S, Henderson LE, Korber B, Jeang K-T, Pavlakis GN (eds) (1995): Human retroviruses and AIDS. A compilation and analysis of nucleic acid and amino acid sequences. Los Alamos National Laboratory, Los Alamos
Rice NR, Henderson LE, Sowder RC, Copeland TD, Oroszlan S, Edwards JF (1990) Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus. J Virol 64: 3770–3778
Hunter E, Hill E, Hardwick JM, Bhown A, Schwartz DE, Tizard R (1983) Complete sequence of the Rous sarcoma virus Env gene: identification of structural and functional regions of its product. J Virol 46: 920–936
Chou PY, Fasman GD (1978) Predictions of the secondary structure of proteins from their amino acid sequence. Annu Rev Biochem 47: 251–276
Garnier J, Osguthorpe DJ, Robson B (1978) Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol 120: 97–120
Clavel F, Guetard D, Brun-Vezinet F, Chamaret S, Rey M-A, Santos-Ferreira MO, Laurent AG, Dauguet C, Katlama C, Rouzioux C, Klatzmann D, Champalimaud JL, Montagnier L (1986) Isolation of a new human retrovirus from West African patients with AIDS. Science 233: 343–346
Chakrabarti L, Emerman M, Tiollais P, Sonigo P (1989) The cytoplasmic domain of simian immunodeficiency virus transmembrane protein modulates infectivity. J Virol 63: 4395
Hirsch VM, Edmondson P, Murphey-Corb M, Arbeille B, Johnson PR, Mullins JI (1989) SIV adaptation to human cells. Nature 341: 573–574
Kodama T, Wolley DP, Naidu YM, Kestler HW, Daniel MD, Li Y, Desrosiers RC (1989) Significance of premature stop codons in env of simian immunodeficiency virus. J Virol 63: 4709–4714
Zagury JF, Franchini G, Reitz M, Collalti E, Starcich B, Hall L, Fargnoli L, Jagozinski L, Guo H-G, Laure F, Arya SK, Josephs S, Zagury D, Wong-Staal F, Gallo RC (1988). Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1. Proc Natl Acad Sci USA 85: 5941–5945
Shimizu H, Hasebe F, Tsuchie H, Mirikawa S, Ushijima H, Kitamura T (1992) Analysis of a human immunodeficiency virus type 1 isolate carrying a truncated transmembrane glycoprotein. Virology 189: 534–546
Zaides V, Yagello M, Veselovskaya T, Schmitt D, Rykova L, Fenouillett E, Gluckman JC (1994) Extensive C-terminal deletion in human immunodeficiency virus type 1 Env glycoprotein arising after long-term culture of chronically infected cells. J Gen Virol 75: 2963–2975
Venable RM, Pastor RW, Brooks BR, Carson FW (1989) Theoretically determined three-dimensional structures for amphipathic segments of HIV-1 gp41 envelope protein. AIDS Res Hum Retroviruses 5: 7–22
Eisenberg D, Wesson M (1990) The most amphiphilic alpha-helices include two amino acid segments in human immunodeficiency virus glycoprotein 41. Biopolymers 29: 171–177
Miller MA, Garry RT, Jaynes JM, Montelaro RC (1991) A structural correlation between lentiviral transmembrane proteins and natural cytolytic peptides. AIDS Res Hum Retroviruses 7: 511–519
Srinivas SK, Srinivas RV, Anantharamaiah GM, Segrest JP, Compans RW (1992) Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein. J Biol Chem 267: 7121–7127
Gawrisch K, Han K-H, Yang J-S, Bergelson J-D, Ferretti JA (1993) Interaction of peptide fragment 828–848 of the envelope glycoprotein of human immunodeficiency virus type 1 with lipid bilayers. Biochemistry 32: 3112–3118
Chernomordik L, Chanturiya AN, Suss-Toby E, Nora E, Zimmerberg J (1994) An amphipathic peptide from the C-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in membranes. J Virol 68: 7115–7123
Miller MA, Cloyd MW, Liebmmann J, Rinaldo CR, Islam KR, Wang SZS, Mietzner TA, Montelaro RC (1993) Alterations in cell membrane permeability by the lentiviral lytic peptide (LLP-1) of HIV-1 transmembrane protein. Virology 196: 89–100
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berkhout, B., van Wamel, J.L.B. Identification of a novel splice acceptor in the HIV-1 genome: independent expression of the cytoplasmic tail of the envelope protein. Archives of Virology 141, 839–855 (1996). https://doi.org/10.1007/BF01718159
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01718159